References
- Tsang KL, Ho SL, Lo SK. Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations. Neurology 2000;54:2292–8.
- Bédard PJ, Langelier P, Dankova J et al. Estrogens, progesterone, and the extrapyramidal system. Adv in Neurol 1979;24: 411–22.
- Teive AG, Munhoz RP, Werneck LC. Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure. Mov Disord 2007;22:1678–9.
- Quinn NP, Marsden CD. Menstrual-related fluctuations in Parkinson's disease. Mov Disord 1986;1:85–7.
- Blanchet PJ, Fang J, Hyland K Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover study. Neurology 1999;53:91–5.
- Sasson S, Notides AC. Estriol and estrone interaction with the estrogen receptor. I. Temperature-induced modulation of the cooperative binding of [3H]estriol and [3H]estrone to the estrogen receptor. J Biol Chem 1983;258:8113–7.
- Xie T, Ho SL, Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 1999;56: 31–8.
- Morissette M, Di Paolo T. Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys. J Neurosci Res 2009;87:1634–44.
- Roy EJ, Buyer DR, Licari VA. Estradiol in the striatum: effects on behavior and dopamine receptors but no evidence for membrane steroid receptors. Brain Res Bull 1990;25:221–7.